Author

Kalliopi Zachou

Associate Professor in Medicine, University of Thessaly, Faculty of Medicine - Cited by 6,003 - Internal Medicine - Hepatology - Autoimmune liver diseases

Biography

Kalliopi Zachou works at the Department of Medicine, Medical School, University of Thessaly, Larissa, Greece, also a well-known researcher, one of his famous works are Quiz: Sternoclavicular Joint Swelling in a Previously Healthy Adult
Title
Cited by
Year
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group
S Pape, RJ Snijders, TJG Gevers, O Chazouilleres, GN Dalekos, ...Journal of hepatology 76 (4), 841-849, 2022202
39
2022
Predictors of hepatitis B surface antigen loss, relapse and retreatment after discontinuation of effective oral antiviral therapy in noncirrhotic HBeAg‐negative chronic hepatitis B
M Papatheodoridi, E Hadziyannis, F Berby, K Zachou, B Testoni, ...Journal of Viral Hepatitis 27 (2), 118-126, 2020202
37
2020
Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis
P Arvaniti, G Giannoulis, S Gabeta, K Zachou, GK Koukoulis, GN DalekosJHEP Reports 2 (4), 100123, 2020202
34
2020
JAK inhibitors suppress innate epigenetic reprogramming: a promise for patients with Sjögren’s syndrome
A Charras, P Arvaniti, C Le Dantec, MI Arleevskaya, K Zachou, ...Clinical Reviews in Allergy & Immunology 58, 182-193, 2020202
32
2020
Update of the simplified criteria for autoimmune hepatitis: Evaluation of the methodology for immunoserological testing
J Galaski, C Weiler-Normann, M Schakat, K Zachou, P Muratori, ...Journal of Hepatology 74 (2), 2-320, 2021202
31
2021
JAK inhibitors and oxidative stress control
A Charras, P Arvaniti, C Le Dantec, GN Dalekos, K Zachou, A Bordron, ...Frontiers in Immunology 10, 2814, 2019201
29
2019
NAFLD and autoimmune hepatitis: do not judge a book by its cover
GN Dalekos, NK Gatselis, K Zachou, GK KoukoulisEuropean journal of internal medicine 75, 1-9, 2020202
28
2020
Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients
NK Gatselis, T Tornai, Z Shums, K Zachou, A Saitis, S Gabeta, R Albesa, ...World Journal of Gastroenterology 26 (34), 5130, 2020202
28
2020
Features and outcome of AIH patients without elevation of IgG
J Hartl, R Miquel, K Zachou, GW Wong, A Asghar, S Pape, M Sebode, ...JHEP reports 2 (3), 100094, 2020202
27
2020
Permanent immunosuppression in SLA/LP‐positive autoimmune hepatitis is required although overall response and survival are similar
K Zachou, C Weiler‐Normann, L Muratori, P Muratori, AW Lohse, ...Liver International 40 (2), 368-376, 2020202
27
2020
Factors associated with progression and outcomes of early stage primary biliary cholangitis
NK Gatselis, JC Goet, K Zachou, WJ Lammers, HLA Janssen, ...Clinical Gastroenterology and Hepatology 18 (3), 684-692. e6, 2020202
15
2020
Impact of genetic and environmental factors on autoimmune hepatitis
K Zachou, P Arvaniti, A Lyberopoulou, GN DalekosJournal of Translational Autoimmunity 4, 100125, 2021202
14
2021
Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis
R Taubert, B Engel, J Diestelhorst, KL Hupa‐Breier, P Behrendt, ...Hepatology 75 (1), -27, 2022202
13
2022
Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis
A Laschtowitz, K Zachou, V Lygoura, S Pape, F Derben, E Jaeckel, ...JHEP reports 3 (4), 100321, 2021202
12
2021
Serum cartilage oligomeric matrix protein and Golgi protein-73: new diagnostic and predictive tools for liver fibrosis and hepatocellular cancer?
NK Gatselis, K Zachou, G Giannoulis, S Gabeta, GL Norman, GN DalekosCancers 13 (14), 3510, 2021202
11
2021
FibroMeter scores for the assessment of liver fibrosis in patients with autoimmune liver diseases
K Zachou, V Lygoura, P Arvaniti, G Giannoulis, NK Gatselis, GK Koukoulis, ...Annals of hepatology 22, 100285, 2021202
9
2021
Epigenetic modifications in generalized autoimmune epithelitis: Sjögren’s syndrome and primary biliary cholangitis
P Arvaniti, K Zachou, A Lyberopoulou, NK Gatselis, WH Brooks, ...Epigenomes 3 (3), 15, 20120
9
2019
First results from a propensity matching trial of mycophenolate mofetil vs. azathioprine in treatment-naive AIH patients
GN Dalekos, P Arvaniti, NK Gatselis, A Samakidou, S Gabeta, ...Frontiers in Immunology 12, 78602, 2022202
9
2022
Efficient management of secondary haemophagocytic lymphohistiocytosis with intravenous steroids and γ-immunoglobulin infusions
S Georgiadou, NK Gatselis, A Stefos, K Zachou, K Makaritsis, ...World Journal of Clinical Cases 7 (21), 334, 20120
9
2019
Hepatocellular carcinoma after treatment cessation in non‐cirrhotic HBeAg‐negative chronic hepatitis B: A multicentre cohort study
M Papatheodoridi, TH Su, E Hadziyannis, CH Liao, Α Orfanidou, HC Yang, ...Liver International 42 (3), 541-550, 2022202
8
2022

Referred From: https://scholar.google.com/citations?hl=en&user=Wupt_L4AAAAJ

Cited by
Citations 6003
h-index 43
i10-index 92
Recommended Journals
Open Access Journals